Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Ann Intern Med
1 Arch Dis Child
1 BMC Cancer
2 HIV Med
6 J Acquir Immune Defic Syndr
2 J Immunol
3 J Infect Dis
2 J Virol
1 MMWR Morb Mortal Wkly Rep
2 Pediatr Infect Dis J
23 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Virology


  1. LEE GQ, Bangsberg DR, Mo T, Lachowski C, et al
    Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001619.
    >> Share

  2. YIN MT, Chan ES, Brown TT, Tebas P, et al
    Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation: ACTG A5280.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001621.
    >> Share

  3. ANDERSON JC, Grace KT, Miller E
    Reproductive coercion among women living with HIV: an unexplored risk factor for negative sexual and mental health outcomes.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001620.
    >> Share

  4. MILLS JC, Harman JS, Cook RL, Marlow NM, et al
    Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001618.
    >> Share

  5. FOURMAN LT, Czerwonka N, Feldpausch MN, Weiss J, et al
    Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001614.
    >> Share

  6. GANDHI M, Murnane PM, Bacchetti P, Elion R, et al
    Hair Levels of PrEP Drugs Measure Adherence and are Associated with Renal Decline Among Men/Transwomen in an Open Label PrEP Study.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001615.
    >> Share

  7. SALADINI F, Giannini A, Boccuto A, Tiezzi D, et al
    The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro.
    AIDS. 2017 Aug 21. doi: 10.1097/QAD.0000000000001616.
    >> Share

    AIDS Res Hum Retroviruses

  8. JEON C, Lau C, Kendall CE, Burchell AN, et al
    Mortality and health service use following acute myocardial infarction among persons with HIV: a population-based study.
    AIDS Res Hum Retroviruses. 2017 Aug 17. doi: 10.1089/AID.2017.0128.
    >> Share

    Am J Epidemiol

  9. SHEPHERD BE, Blevins Peratikos M, Rebeiro PF, Duda SN, et al
    A Pragmatic Approach for Reproducible Research With Sensitive Data.
    Am J Epidemiol. 2017;186:387-392.
    >> Share

    Ann Intern Med

  10. GULICK RM, Wilkin TJ, Chen YQ, Landovitz RJ, et al
    Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
    Ann Intern Med. 2017 Aug 22:1-10. doi: 10.7326/M17-0520.
    >> Share

    Arch Dis Child

  11. CURRY C, Zuhlke L, Mocumbi A, Kennedy N, et al
    Acquired heart disease in low-income and middle-income countries.
    Arch Dis Child. 2017 Aug 24. pii: archdischild-2016-312521.
    >> Share

    BMC Cancer

  12. NKANGA MSN, Longo-Mbenza B, Adeniyi OV, Ngwidiwo JB, et al
    Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
    BMC Cancer. 2017;17:559.
    >> Share


    Could cancer research hold the key to a cure for HIV?
    BMJ. 2017;358:j3905.
    >> Share

    HIV Med

  14. CUZIN L, Yazdanpanah Y, Huleux T, Cotte L, et al
    No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
    HIV Med. 2017 Aug 18. doi: 10.1111/hiv.12545.
    >> Share

  15. DE POKOMANDY A, Rouleau D, Lalonde R, Beauvais C, et al
    Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.
    HIV Med. 2017 Aug 23. doi: 10.1111/hiv.12544.
    >> Share

    J Acquir Immune Defic Syndr

  16. VOJNOV L, Markby J, Boeke C, Penazzato M, et al
    Impact of SMS/GPRS printers in reducing time to early infant diagnosis compared to routine result reporting: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001526.
    >> Share

  17. DILLON SM, Castleman MJ, Frank DN, Austin GL, et al
    Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001523.
    >> Share

  18. NORWOOD J, Koethe JR, Turner M, Bofill C, et al
    Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001525.
    >> Share

  19. PINTYE J, Bacchetti P, Teeraananchai S, Kerr S, et al
    Brief Report: Lopinavir Hair Concentrations are the Strongest Predictor of Viremia in HIV-infected Asian Children and Adolescents on Second-line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001527.
    >> Share

  20. HOFFMAN S, Tymejczyk O, Kulkarni S, Lahuerta M, et al
    Stigma And HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART.
    J Acquir Immune Defic Syndr. 2017 Aug 22. doi: 10.1097/QAI.0000000000001530.
    >> Share

  21. SMITH DK, Van Handel M, Huggins R
    Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015.
    J Acquir Immune Defic Syndr. 2017 Aug 22. doi: 10.1097/QAI.0000000000001532.
    >> Share

    J Immunol

  22. ACHLEITNER M, Kleefisch M, Hennig A, Peschke K, et al
    Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs.
    J Immunol. 2017 Aug 23. pii: ji1700714. doi: 10.4049/jimmunol.1700714.
    >> Share

  23. GAMAGE AM, Lee KO, Gan YH
    Anti-Cancer Drug HMBA Acts as an Adjuvant during Intracellular Bacterial Infections by Inducing Type I IFN through STING.
    J Immunol. 2017 Aug 21. pii: ji1602162. doi: 10.4049/jimmunol.1602162.
    >> Share

    J Infect Dis

  24. HORNER PJ, Martin DH
    Mycoplasma genitalium Infection in Men.
    J Infect Dis. 2017;216.
    >> Share

  25. MARTIN DH, Manhart LE, Workowski KA
    Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.
    J Infect Dis. 2017;216.
    >> Share

  26. HENRICH TJ, Hobbs KS, Hanhauser E, Scully E, et al
    Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
    J Infect Dis. 2017;216:254-262.
    >> Share

    J Virol

  27. ANSTETT K, Brenner B, Mesplede T, Wainberg MA, et al
    HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.
    J Virol. 2017 Aug 23. pii: JVI.00912-17. doi: 10.1128/JVI.00912.
    >> Share

  28. WANG Y, O'Dell S, Turner HL, Chiang CI, et al
    HIV-1 Cross-reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Non-human Primate.
    J Virol. 2017 Aug 23. pii: JVI.00910-17. doi: 10.1128/JVI.00910.
    >> Share

    MMWR Morb Mortal Wkly Rep

  29. PITASI MA, Oraka E, Clark H, Town M, et al
    HIV Testing Among Transgender Women and Men - 27 States and Guam, 2014-2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:883-887.
    >> Share

    Pediatr Infect Dis J

  30. BOSIRE R, Farquhar C, Nduati R, Broliden K, et al
    Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine.
    Pediatr Infect Dis J. 2017 Aug 19. doi: 10.1097/INF.0000000000001749.
    >> Share

  31. NDONGO FA, Texier G, Penda CI, Tejiokem MC, et al
    Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon.
    Pediatr Infect Dis J. 2017 Aug 23. doi: 10.1097/INF.0000000000001745.
    >> Share

    PLoS One

  32. DE WEGGHELEIRE A, An S, De Baetselier I, Soeung P, et al
    A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.
    PLoS One. 2017;12:e0183530.
    >> Share

  33. VARANI S, Ortalli M, Attard L, Vanino E, et al
    Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy.
    PLoS One. 2017;12:e0183699.
    >> Share

  34. CHEN Q, Wu H, Tao J, Liu C, et al
    Effect of naringin on gp120-induced injury mediated by P2X7 receptors in rat primary cultured microglia.
    PLoS One. 2017;12:e0183688.
    >> Share

  35. NANGENDO J, Obuku EA, Kawooya I, Mukisa J, et al
    Diagnostic accuracy and acceptability of rapid HIV oral testing among adults attending an urban public health facility in Kampala, Uganda.
    PLoS One. 2017;12:e0182050.
    >> Share

  36. HOHN O, Norley S, Kucherer C, Bazarbachi A, et al
    No significant HTLV seroprevalence in German people who inject drugs.
    PLoS One. 2017;12:e0183496.
    >> Share

  37. BUTT ZA, Shrestha N, Wong S, Kuo M, et al
    A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
    PLoS One. 2017;12:e0183609.
    >> Share

  38. JAYA Z, Drain PK, Mashamba-Thompson TP
    Evaluating quality management systems for HIV rapid testing services in primary healthcare clinics in rural KwaZulu-Natal, South Africa.
    PLoS One. 2017;12:e0183044.
    >> Share

  39. ROYSE KE, El Chaer F, Amirian ES, Hartman C, et al
    Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013.
    PLoS One. 2017;12:e0182750.
    >> Share

  40. CASSIM N, Coetzee LM, Schnippel K, Glencross DK, et al
    Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.
    PLoS One. 2017;12:e0182154.
    >> Share

  41. GOPALAN BP, Mehta K, D'souza RR, Rajnala N, et al
    Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring.
    PLoS One. 2017;12:e0183080.
    >> Share

  42. LEVY ME, Patrick R, Gamble J, Rawls A, et al
    Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis.
    PLoS One. 2017;12:e0183521.
    >> Share

  43. BENNANI A, El-Kettani A, Hancali A, El-Rhilani H, et al
    The prevalence and incidence of active syphilis in women in Morocco, 1995-2016: Model-based estimation and implications for STI surveillance.
    PLoS One. 2017;12:e0181498.
    >> Share

  44. ROBINSON JL, Narasimhan M, Amin A, Morse S, et al
    Interventions to address unequal gender and power relations and improve self-efficacy and empowerment for sexual and reproductive health decision-making for women living with HIV: A systematic review.
    PLoS One. 2017;12:e0180699.
    >> Share

  45. ADENIYI OV, Ajayi AI, Selanto-Chairman N, Goon DT, et al
    Demographic, clinical and behavioural determinants of HIV serostatus non-disclosure to sex partners among HIV-infected pregnant women in the Eastern Cape, South Africa.
    PLoS One. 2017;12:e0181730.
    >> Share

  46. KALU AW, Telele NF, Gebreselasie S, Fekade D, et al
    Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort.
    PLoS One. 2017;12:e0182384.
    >> Share

  47. PRIETO LM, Fernandez McPhee C, Rojas P, Mazariegos D, et al
    Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015.
    PLoS One. 2017;12:e0183558.
    >> Share

  48. STEFIC K, Chaillon A, Bouvin-Pley M, Moreau A, et al
    Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties.
    PLoS One. 2017;12:e0181680.
    >> Share

  49. CALAZANS A, Boggiano C, Lindsay R
    A DNA inducing VLP vaccine designed for HIV and tested in mice.
    PLoS One. 2017;12:e0183803.
    >> Share

  50. DOYLE AM, Plummer ML, Weiss HA, Changalucha J, et al
    Concurrency and other sexual partnership patterns reported in a survey of young people in rural Northern Tanzania.
    PLoS One. 2017;12:e0182567.
    >> Share

  51. MOORE RC, Paolillo EW, Heaton A, Fazeli PL, et al
    Clinical utility of the UCSD Performance-Based Skills Assessment-Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties.
    PLoS One. 2017;12:e0183614.
    >> Share

  52. CHIACCHIO T, Delogu G, Vanini V, Cuzzi G, et al
    Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    PLoS One. 2017;12:e0183846.
    >> Share

  53. KULP JL 3RD, Cloudsdale IS, Kulp JL Jr, Guarnieri F, et al
    Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition.
    PLoS One. 2017;12:e0183327.
    >> Share

  54. TLOU B, Sartorius B, Tanser F
    Space-time variations in child mortality in a rural South African population with high HIV prevalence (2000-2014).
    PLoS One. 2017;12:e0182478.
    >> Share

    PLoS Pathog

  55. BURDICK RC, Delviks-Frankenberry KA, Chen J, Janaka SK, et al
    Dynamics and regulation of nuclear import and nuclear movements of HIV-1 complexes.
    PLoS Pathog. 2017;13:e1006570.
    >> Share

    Proc Natl Acad Sci U S A

  56. CHAN AH, Lee WG, Spasov KA, Cisneros JA, et al
    Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography.
    Proc Natl Acad Sci U S A. 2017 Aug 21. pii: 201711463.
    >> Share


  57. MOLAN AM, Hanson HM, Chweya CM, Anderson BD, et al
    APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.
    Virology. 2017;511:74-81.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016